At-Home Testing Market Trends, Size, Top Leaders, Future Scope and Outlook 2030

Comments · 38 Views

Self-tests detect current infection and are sometimes also called home tests, or over-the-counter (OTC) tests. At-home testing means testing instruments that help people perform tests at home and give them rapid results in a minute

At-Home Testing Market size was valued at USD 12.73 Billion in 2023 and the total At-Home Testing Revenue is expected to grow at a CAGR of 8.2 % from 2024 to 2030, reaching nearly USD 22.10 Billion in 2030.

At-Home Testing Market Overview:

This study categorizes the At-Home Testing market to anticipate revenues and analyze trends in each of the sub-markets listed below.

Market Scope:

The competition strategic window researches the competitive environment in terms of markets, applications, and regions to assist the vendor in defining an alignment or fit between their strengths and future growth opportunities.It describes the optimum or most beneficial fit for vendors to pursue sequential merger and acquisition tactics, regional expansion, RD, and new product launch techniques to execute future business expansion and growth over a projected period.

Details insights on this market, request for methodology here@https://www.maximizemarketresearch.com/request-sample/189935 

Segmentation:

by Product

Kits
Devices
Strips


by Sample

Blood
Urine
Stool
by Application Blood Pressure Test
Diabetes and Glucose Tests
Cholesterol and Triglycerides Tests
Pregnancy Test
STD /STI Test
Urinary Tract Infection Test
Cancer Test
Celiac disease Test
Thyroid Test
Transaminase Test
Anemia Test
Allergy Test
by End-User Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

Key Players:

1. BD (Becton, Dickinson and Company) (U.S.)
2. LifeScan IP Holdings, LLC (U.S.)
3. Abbott (U.S.)
4. ACON Laboratories, Inc. (U.S.)
5. Quidel Corporation (U.S.)
6. ARKRAY USA, Inc. (U.S.)
7. Nova Biomedical (U.S.)
8. Cardinal Health (U.S.)
9. OraSure Technologies (U.S.)
10. Everlywell, Inc. (U.S.)
11. SA Scientific Ltd. (U.S.)
12. MP BIOMEDICALS (U.S.)
13. Chembio Diagnostics, Inc. (U.S.)
14. BTNX INC. (Canada)
15. Biolytical Laboratories Inc. (Canada)
16. Siemens Healthcare GmbH (Germany)
17. Drägerwerk AG Co. KGaA (Germany)
18. F. Hoffmann-La Roche Ltd (Switzerland)
19. Ascensia Diabetes Care Holdings AG (Switzerland)
20. PRIMA Lab SA (Switzerland)
21. BioSure (U.K.)
22. Sterilab Services (France)
23. Biosynex (France)

Regional Analysis:

The At-Home Testing market prediction research is created after a thorough examination of many geographical areas, including Asia-Pacific, Europe, North America, and the rest of the globe. North America has the greatest power over the At-Home Testing market share and will continue to be a major shareholder in the global At-Home Testing market.

COVID-19 Impact Analysis on At-Home Testing Market:

The impact of COVID-19 pandemic on At-Home Testing market has also been included in the report.

Please contact us:https://www.maximizemarketresearch.com/market-report/at-home-testing-market/189935/ 

Key Questions Answered in the At-Home Testing Market Report are:

  • Which are the prominent players in the At-Home Testing market?
  • What key trends are likely to emerge in the At-Home Testing market in the coming years?
  • What will be the At-Home Testing market size by 2030?
  • Which company held the largest share in the At-Home Testing market?


About us:

MAXIMIZE MARKET RESEARCH PVT. LTD.

3rd Floor, Navale IT park Phase 2,

Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
+91 9607365656
[email protected]

 

Comments